Syndicate Feeds
HIVandHepatitis.com Ribavirin Helps Early HepC HCV Treatment in People with HIV: http://t.co/gZVdVEB6Monday, 14 May 2012 14:41
HIVandHepatitis.com Researchers Identify Compounds that May Block HPV 's Ability to Cause Cancer: http://t.co/QeP2dRO3Monday, 14 May 2012 14:40
HIVandHepatitis.com FDA Advisors Favor Approval of 4-in-1 Elvitegravir Quad Pill for HIV AIDS: http://t.co/lOgWAW7nFriday, 11 May 2012 13:45
HIVandHepatitis.com Another day, another OK: FDA Advisors Favor Approval of Gilead's 4-in-1 Quad Pill for HIV AIDSFriday, 11 May 2012 12:08
- Error
EASL: Ribavirin Dose Reduction Is Effective for Managing Anemia in Patients Using Boceprevir or Telaprevir
Reducing the dose of ribavirin and adding erythropoietin are both good options for managing anemia in hepatitis C patients treated with boceprevir (Victrelis) triple therapy, according to study findings presented at the 47th International Liver Congress (EASL 2012) this week in Barcelona. A related study found that ribavirin reduction also did not impair cure rates with telaprevir (Incivek).
HIV/AIDS
HIV Gene Therapy Shows Long-term Safety and Activity after 11 Years
Genetically modified T-cells engineered to attack HIV were still present and sho...
FDA Committee Will Consider Approval of Truvada for HIV PrEP this Thursday
On May 10, 2012, the Antiviral Drugs Advisory Committee of the U.S. Food and Dru...
Oral HIV Tests May Be Less Accurate than Blood Tests
Oral HIV antibody testing is quick and convenient, but this method is not quite ...
ACT UP at 25
The AIDS Coalition to Unleash Power, better known as ACT UP, held its first majo...
Hepatitis B
EASL: Telbivudine Effective for Hepatitis B Patients Selected with Roadmap
Telbivudine (Tyzeka) is an effective treatment for chronic hepatitis B with mini...
CDC Advisory Committee Recommends Hepatitis B Vaccine for People with Diabetes
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immun...
Interpreting Hepatitis B Tests
The following table from the U.S. Centers for Disease Control and Prevention (CD...
EASL: Brivanib Did Not Improve Overall Liver Cancer Survival, but Did Show Anti-tumor Activity
The experimental cancer drug brivanib did not lengthen overall survival for pati...
Hepatitis C
EASL: MicroRNA Miravirsen Looks Safe and Effective for Genotype 1 Hepatitis C
Miravirsen, the first microRNA therapy for hepatitis C, was well-tolerated and d...
Scientists Find Antibodies that Neutralize Multiple Strains of Hepatitis C Virus
As described in a report published in the April 4, 2012, online edition of Proceed...
AASLD: HCV Screening of 1945-1965 Birth Cohort Appears Cost-Effective
Screening all people in the U.S. in the 46 to 66 year age group for hepatitis C ...
Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin
Hepatitis C patients who develop anemia during treatment with pegylated int...
Coinfection
CROI: Detectable HIV Raises Risk of Incomplete Hepatitis B Suppression
HIV/HBV coinfected people with detectable HIV viral load and higher baseline HBV...
EASL: Boceprevir Improves Cure Rates for HIV/HCV Coinfection but Beware of Drug Interactions
Adding boceprevir (Victrelis) to pegylated interferon and ribavirin for treatmen...
Other Infections
March 24 is World TB Day
Tuberculosis (TB) is the leading cause of death for people with HIV worldwide --...
Researchers Report Setbacks on Herpes Simplex Vaccine and Treatment
An experimental herpes simplex virus (HSV) vaccine partially protected women aga...
AASLD: High Rate of Cancer-Causing HPV among Women with Hepatitis C Awaiting Liver Transplants
Nearly 1 in 5 women undergoing liver transplantation -- most of them due to chro...
Hepatitis E Uncommon among HIV+ People, but May Cause Unexplained Liver Enzyme Elevations
Coinfection with hepatitis E virus (HEV) is not commonly seen in people with HIV...
CONTINUING MEDICAL EDUCATION
Subscribe To Our Newsletter
Sign up for our free twice-weekly e-newsletter
CONFERENCE COVERAGE
47th International Liver Congress (EASL 2012)
April 18-22, 2012, Barcelona
|
19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) |
|
|
The Liver Meeting (AASLD 2011) |
|
|
49th Annual Meeting of the Infectious Disease Society of America (IDSA 2011) |
|
|
13th European AIDS Conference (EACS 2011) |
|
|
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) |
|
|
6th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2011) |
|
|
|
46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011) March 30-Apr. 3, 2011, Berlin |
|
|
18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) |
